Gulay Hergenc
Overview
Explore the profile of Gulay Hergenc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Sansoy V, Hergenc G, et al.
Clin Chem Lab Med
. 2011 Oct;
50(2):285-92.
PMID: 22004016
Background: Apolipoprotein C3 (APOC3) gene polymorphisms are associated with cardiometabolic risk factors, varying in ethnicities. This study aimed to investigate such association between the APOC3 -482C>T polymorphism and cardiometabolic risk...
2.
Onat A, Hergenc G, Can G, Ugur M, Nartop F
Clin Chem Lab Med
. 2011 Jul;
49(8):1349-1357.
PMID: 21756164
Background: The clinical relevance of serum lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in populations prone to cardiometabolic risk needs exploration. We determined major covariates of Lp-PLA(2) mass, and its associations with cardiometabolic...
3.
Onat A, Can G, Kaya H, Hergenc G
J Clin Lipidol
. 2010 Dec;
4(2):89-98.
PMID: 21122635
Objectives: To determine the association of atherogenic index of plasma (AIP), the logarithm of molar ratio of triglyceridemia to high-density lipoprotein cholesterol (TG/HDL-cholesterol) with cardiometabolic disorders was investigated in a...
4.
Komurcu-Bayrak E, Onat A, Yuzbasiogullari B, Mononen N, Laaksonen R, Kahonen M, et al.
Metabolism
. 2010 Aug;
60(5):655-63.
PMID: 20723945
The -219G/T (rs405509) and +113G/C (rs440446) polymorphisms within the regulatory region of the apolipoprotein E (APOE) gene have been related to the transcriptional activity of the gene. We examined the...
5.
Onat A, Hergenc G
Anadolu Kardiyol Derg
. 2010 Aug;
10(4):384.
PMID: 20693141
No abstract available.
6.
Onat A, Hergenc G
Metabolism
. 2010 Jun;
60(4):499-512.
PMID: 20580781
Dysfunction of high-density lipoprotein (HDL) particles that even become proinflammatory or lose atheroprotective properties is known through analyses of HDL isolated from diabetic subjects. Recently, high concentrations of HDL or...
7.
Onat A, Can G, Hergenc G, Kucukdurmaz Z, Ugur M, Yuksel H
Cardiology
. 2010 Apr;
115(4):297-306.
PMID: 20395681
Objectives: To confirm previous findings on excess absolute coronary heart disease (CHD) risk among Turks. Methods: The observed incident CHD risk of a representative population sample was compared with that...
8.
Onat A, Komurcu-Bayrak E, Can G, Kucukdurmaz Z, Hergenc G, Erginel-Unaltuna N
Nutrition
. 2010 Feb;
26(10):975-80.
PMID: 20116212
Objective: Given the elevated apolipoprotein (apo) A-I level enhancement of type 2 diabetes among Turks, the interrelation among it, apoB, and apoE genotype with respect to the likelihood of diabetes...
9.
Onat A, Hergenc G, Can G
Turk Kardiyol Dern Ars
. 2009 Dec;
37(6):425-34.
PMID: 20019460
Knowledge obtained from the Turkish Adult Risk Factor (TARF) study on higher morbidity and mortality rates compared to other populations from coronary heart disease (CHD) among Turkish adults has been...
10.
Onat A, Hergenc G, Can G, Kaya Z, Yuksel H
Metabolism
. 2009 Nov;
59(5):628-34.
PMID: 19913840
We studied whether serum complement C3 (C3) is an independent determinant of incident cardiometabolic risk (coronary heart disease [CHD], metabolic syndrome [MetS], and type 2 diabetes mellitus). A cohort of...